Clin2
NCT07726069Possibly a fitNot yet recruiting

Haloperidol for nausea caused by cannabis use in the ER

Cannabinoid Hyperemesis Syndrome

Treatments studied

Part of Blood & lymphatic, Eyes & vision, Genetic & congenital, Immune system & allergy, Mental health clinical trials.

This study is testing whether a medicine called haloperidol can help manage symptoms of a condition linked to heavy cannabis use, called cannabinoid hyperemesis syndrome (which causes severe nausea and vomiting). If you often use cannabis and have these symptoms, this treatment might help you feel better while you are in the emergency room.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
100 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be 18 or older.
  • You are coming to the emergency room for sudden or repeated nausea, vomiting, or belly pain.
  • You use cannabis often (at least a few times a week).
  • You also need to have at least one of these: past episodes of severe nausea and vomiting that come and go, or feeling better after a hot shower or bath, or your symptoms started or got worse after using cannabis.
  • You cannot have another condition that explains your symptoms, and you cannot be pregnant, breastfeeding, or have certain heart rhythm problems.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06660901Recruiting
Study on cannabis use and vomiting in emergency rooms

This study looks at patients who come to the ER with belly pain or vomiting and uses cannabis, to better understand a condition called cannabinoid hyperemesis syndrome (severe nausea and vomiting caused by long-term cannabis use). If you're eligible, you'll answer a few questions to help doctors learn more.

Angers
NCT06395428Recruiting· Phase 4
Haloperidol for severe back pain in the ER

This study tests whether the medication haloperidol, given in the emergency room, can help relieve severe back pain that started on its own (not from an injury). It compares haloperidol to a common pain reliever called ketorolac.

Kalamazoo, Michigan
NCT07374939Not yet recruiting
Medical cannabis for chemotherapy nausea

This study looks at whether medical cannabis (marijuana) helps reduce nausea and vomiting caused by chemotherapy. If you join, you'll receive a cannabis product and track how well it works over several cycles.

Rochester, New York
NCT06859710Recruiting· Phase 1
THC and CBD as a harm reduction strategy

This study looks at whether different types of cannabis (containing THC and/or CBD) might help people who use cannabis regularly reduce potential harms. You will be asked to take cannabis in a controlled setting and complete tasks and questionnaires.

Los Angeles, California
NCT07216690Recruiting· Phase 2
Pregnenolone for cannabis intoxication

This study tests whether a natural hormone called pregnenolone can reduce the effects of cannabis intoxication. You'll receive either the study drug or a placebo, then eat a cannabis-containing brownie to see how your body reacts.

Baltimore, Maryland
NCT07471347Not yet recruiting
Cannabidiol effects on cannabis tolerance in heavy users

This study tests whether taking cannabidiol (CBD) through a special vaporizer can change how your body responds to cannabis, especially if you're a heavy user. It might help understand if CBD can reduce tolerance or dependence.

London

Hear when a new Cannabinoid Hyperemesis Syndrome trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.